Gross Profit (Annual) Chart

View Gross Profit (Annual) for SLNCF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit (Annual) Chart
Start Trial

Historical Gross Profit (Annual) Data

View and export this data back to 1994. Start Trial.
Date Value
December 31, 2025 -0.055M
December 31, 2024 31.19M
December 31, 2023 18.52M
December 31, 2022 7.562M
December 31, 2021 6.233M
December 31, 2020 1.566M
December 31, 2019 0.00
December 31, 2018 -0.532M
December 31, 2017 -0.537M
December 31, 2016 0.6207M
December 31, 2015 -0.2781M
December 31, 2014 -0.522M
December 31, 2013 -0.2814M
December 31, 2012 -0.141M
December 31, 2011 -4.275M
December 31, 2010 -5.335M
Date Value
December 31, 2009 -5.228M
December 31, 2008 -8.256M
December 31, 2007 -1.592M
December 31, 2006 -2.28M
December 31, 2005 -2.091M
December 31, 2004 -2.817M
December 31, 2003 -2.724M
December 31, 2002 -1.958M
December 31, 2001 -3.388M
December 31, 2000 -3.133M
December 31, 1999 -2.720M
December 31, 1998 -2.503M
December 31, 1997 0.00
December 31, 1996 0.00
December 31, 1995 0.00
December 31, 1994 0.00

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (Annual) Range, Past 5 Years

View Gross Profit (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (Annual) Benchmarks

View Gross Profit (Annual) Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc -0.2491M
NuCana Plc -0.3611M
Mereo BioPharma Group Plc -0.7838M
Compass Pathways Plc -0.2165M
HemoGenyx Pharmaceuticals Plc -0.7759M